$AMBQ

Esaka Fumihide sold $869K of AMBQ

Esaka Fumihide (Chief Executive Officer) sold 13,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $64.39 ($63.29–$65.26, $0.87M total) across 3 trades on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Esaka Fumihide
Published Aug 18, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBQ
Neutral
high confidence
Mentioned
$AMBQ
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale size, price range, and post-transaction holdings under a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around AMBQ due to insider selling, but the 10b5-1 framing reduces fundamental interpretation.

03

What to watch

The filing does not state motivations, tax context, or whether other insiders sold/bought around the same time, so interpreting directionality is risky.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-18 after-hours; reflects 2026-08-14 sales

Background

The article is an SEC Form 4 insider transaction for Ambiq Micro, Inc., reported by its CEO.

Company-level read

Ticker impact

$AMBQNeutralHigh confidence
Context

Ambiq Micro CEO Esaka Fumihide sold $869,226 of AMBQ shares via a 10b5-1 plan, with 13,500 shares sold at $63.29 to $65.26.

Expected impact

Likely limited, with any impact more sentiment-driven than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction and explicitly states a pre-arranged Rule 10b5-1 plan; it does not include new guidance, contracts, or regulatory outcomes.

Market effects

Minimal; insider sales in a single semiconductor name typically do not reset sector expectations.

Minimal; no cross-regional or macro linkage is provided.

Minimal; the disclosure is company-specific and does not cite global demand or regulatory changes.

Counterpoint

Because the sale is under a 10b5-1 plan, it may be mechanically scheduled and not a bearish signal; traders may discount it quickly.

Key entities

  • Ambiq Micro, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Esaka Fumihide

    CEO and director who sold 13,500 shares under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.